Joey Med review

Joey Med’s public NAD⁺ selector shows a $300 three-month injection supply. The site mentions a monthly option but did not expose a selectable monthly price in the public selector. Its prescription policy names three fulfillment partners, though none is assigned to a particular NAD⁺ order. The detailed refund page allows a reduced post-shipment refund under conditions; the general terms say dispensed medication is nonrefundable.

Joey Med is a Tampa telehealth storefront operated by MD Telehealth Platform LLC. Its prescription policy names First Choice Pharmacy, VS Digital Pharmacy and Pharmacy Hub Pharmacy as potential fulfillment partners; it does not say which fills a selected NAD⁺ order. The current NAD⁺ selector shows one injection option: $300 for a three-month supply, against a struck-through $350. The site markets service in all 50 states and says insurance is not needed, subject to clinician approval and order-specific availability.

The NAD⁺ page asks for purchase and registration before an online clinician visit; medication ships only after a prescription decision. The detailed refund policy offers a full refund when no prescription is issued or before shipment, and describes a post-shipment refund of the paid amount less $25 shipping and a $199 consultation fee if medication is unused and untampered. General terms instead say dispensed medication is nonrefundable. Product copy suggests quick shipping, while the refund policy allows five to seven business days for processing and another five to seven for transit. Confirm the order-specific refund and delivery terms in writing before paying; the selected dispensing pharmacy and dose remain unknown.

The selected NAD⁺ injection is displayed at $300 for three months, against $350 struck through. The public selector exposed no monthly price despite prose mentioning monthly and three-month choices. The $300 is the displayed selected debit, not a $100 monthly payment. Terms permit address-dependent tax or shipping charges, even though product copy advertises free delivery over $40. The post-shipment refund text conflicts with the general final-sale term, so confirm which governs the selected order.

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The NAD⁺ product page does not assign a pharmacy; a separate policy lists three possible partners. Compounded sterile products are not reviewed by the FDA for purity and potency the way approved drugs are, so ask which pharmacy will fill your prescription before paying. The GLP-1 line does not name its active ingredients on the product pages. On the evidence, the NAD⁺ product is described in the company's own words as commonly used in wellness and anti-aging protocols, which is a statement about usage rather than about outcomes. Injected NAD⁺ has no controlled human outcome trials supporting the energy, recovery or longevity claims the category is sold on; the single human intravenous study was a pharmacokinetic pilot showing infused NAD⁺ clears from plasma quickly. The NAD⁺ forms with human trial data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker, not a demonstrated clinical benefit. Individual results vary.